{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:01:47Z","timestamp":1792602107408,"version":"4.5.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,17]]},"abstract":"<jats:p>Parkinson disease (PD) is the second most common neurodegenerative disease, and its incidence is climbing every year, but there is still a lack of effective clinical treatments. In recent years, many studies have shown that ferroptosis plays a key role in the progression of PD. Most importantly, many cellular and animal studies and clinical trials have shown that episodes of PD can be alleviated by inhibiting the ferroptosis process, such as utilizing inhibitors, chelating agents, and others. Here, we review the role of ferroptosis, a new form of cell death, in the pathogenesis of PD, and summarize the therapeutic strategies for targeting ferroptosis in PD, hoping to provide new thinking for the study of PD pathogenesis and the development of therapeutic strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000041218","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:03:31Z","timestamp":1737410611000},"page":"e41218","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Ferroptosis: a novel pathogenesis and therapeutic strategies for Parkinson disease: A review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7575-9164","authenticated-orcid":false,"given":"Di","family":"Jiao","sequence":"first","affiliation":[{"name":"School of Medicine, Zhengzhou University of Industrial Technology, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medicine, Zhengzhou University of Industrial Technology, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Zhengzhou University of Industrial Technology, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0150-8752","authenticated-orcid":false,"given":"Yaomei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease.","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur J Neurol"},{"key":"R2-20250121","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease.","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"R3-20250121","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA: a scale for the quality assessment of narrative review articles.","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"R4-20250121","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R5-20250121","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death.","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R6-20250121","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"key":"R7-20250121","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis.","volume":"16","author":"Zou","year":"2020","journal-title":"Nat Chem Biol"},{"key":"R8-20250121","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-20250121","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","article-title":"Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides.","volume":"710","author":"Ursini","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"R10-20250121","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.jmedchem.1c01572","article-title":"Targeting regulated cell death with pharmacological small molecules: an update on autophagy-dependent cell death, ferroptosis, and necroptosis in cancer.","volume":"65","author":"Wu","year":"2022","journal-title":"J Med Chem"},{"key":"R11-20250121","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor.","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"R12-20250121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death.","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"key":"R13-20250121","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","article-title":"Parkinson\u2019s disease: alterations in iron and redox biology as a key to unlock therapeutic strategies.","volume":"41","author":"Ma","year":"2021","journal-title":"Redox Biol"},{"key":"R14-20250121","doi-asserted-by":"crossref","first-page":"809","DOI":"10.15252\/embr.201338064","article-title":"sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin.","volume":"15","author":"McCarthy","year":"2014","journal-title":"EMBO Rep"},{"key":"R15-20250121","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1570159X16666180508113025","article-title":"Does ceruloplasmin defend against neurodegenerative diseases?.","volume":"17","author":"Wang","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"R16-20250121","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process.","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res"},{"key":"R17-20250121","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","article-title":"CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation.","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-20250121","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/onc.2015.32","article-title":"HSPB1 as a novel regulator of ferroptotic cancer cell death.","volume":"34","author":"Sun","year":"2015","journal-title":"Oncogene"},{"key":"R19-20250121","doi-asserted-by":"crossref","first-page":"100902","DOI":"10.1016\/j.jpha.2023.11.009","article-title":"Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1\/SLC7A11 axis.","volume":"14","author":"Lin","year":"2024","journal-title":"J Pharm Anal"},{"key":"R20-20250121","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2024.06.020","article-title":"The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson\u2019s disease.","volume":"222","author":"Yao","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"R21-20250121","doi-asserted-by":"crossref","first-page":"1536845","DOI":"10.1080\/23723556.2018.1536845","article-title":"BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression.","volume":"6","author":"Zhang","year":"2019","journal-title":"Mol Cell Oncol"},{"key":"R22-20250121","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41419-021-04307-1","article-title":"Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11.","volume":"12","author":"Dong","year":"2021","journal-title":"Cell Death Dis"},{"key":"R23-20250121","doi-asserted-by":"crossref","first-page":"e1800311","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis.","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"key":"R24-20250121","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/cdd.2015.93","article-title":"Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation.","volume":"23","author":"Hayano","year":"2016","journal-title":"Cell Death Differ"},{"key":"R25-20250121","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/tox.24296","article-title":"STUB1 promotes the degradation of HSPB1 and induces ferroptosis in lung cancer cells.","volume":"39","author":"Tieliwaerdi","year":"2024","journal-title":"Environ Toxicol"},{"key":"R26-20250121","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-021-00862-0","article-title":"Genome-wide CRISPRi\/a screens in human neurons link lysosomal failure to ferroptosis.","volume":"24","author":"Tian","year":"2021","journal-title":"Nat Neurosci"},{"key":"R27-20250121","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain.","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"R28-20250121","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease.","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"key":"R29-20250121","doi-asserted-by":"crossref","first-page":"581191","DOI":"10.3389\/fncel.2020.581191","article-title":"Chemically induced models of Parkinson\u2019s disease: history and perspectives for the involvement of ferroptosis.","volume":"14","author":"Wen","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R30-20250121","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ"},{"key":"R31-20250121","doi-asserted-by":"crossref","first-page":"111231","DOI":"10.1016\/j.celrep.2022.111231","article-title":"Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition.","volume":"40","author":"Mahoney-Sanchez","year":"2022","journal-title":"Cell Rep"},{"key":"R32-20250121","first-page":"130","article-title":"alpha-Syn overexpression","volume":"192","author":"Anandhan","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"R33-20250121","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2016.10.099","article-title":"Antiferroptotic activity of non-oxidative dopamine.","volume":"480","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R34-20250121","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-021-01145-2","article-title":"Cell specific quantitative iron mapping on brain slices by immuno-microPIXE in healthy elderly and Parkinson\u2019s disease.","volume":"9","author":"Friedrich","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"R35-20250121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.freeradbiomed.2018.09.002","article-title":"Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis.","volume":"133","author":"Ishii","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"R36-20250121","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death.","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat Chem Biol"},{"key":"R37-20250121","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2017.06.017","article-title":"Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment.","volume":"58","author":"Song","year":"2017","journal-title":"Neurobiol Aging"},{"key":"R38-20250121","doi-asserted-by":"crossref","first-page":"101789","DOI":"10.1016\/j.redox.2020.101789","article-title":"Protective role of microglial HO-1 blockade in aging: implication of iron metabolism.","volume":"38","author":"Fernandez-Mendivil","year":"2021","journal-title":"Redox Biol"},{"key":"R39-20250121","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease.","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"R40-20250121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0891-5849(98)00021-5","article-title":"(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson\u2019s disease.","volume":"25","author":"Selley","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"R41-20250121","doi-asserted-by":"crossref","first-page":"e13970","DOI":"10.1111\/acel.13970","article-title":"Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress-induced Parkinson\u2019s disease susceptibility.","volume":"22","author":"Lin","year":"2023","journal-title":"Aging Cell"},{"key":"R42-20250121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41589-020-00734-x","article-title":"Phospholipase iPLA(2)beta averts ferroptosis by eliminating a redox lipid death signal.","volume":"17","author":"Sun","year":"2021","journal-title":"Nat Chem Biol"},{"key":"R43-20250121","doi-asserted-by":"crossref","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential.","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R44-20250121","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders.","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol"},{"key":"R45-20250121","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ene.13208","article-title":"Motor associations of iron accumulation in deep grey matter nuclei in Parkinson\u2019s disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.","volume":"24","author":"Martin-Bastida","year":"2017","journal-title":"Eur J Neurol"},{"key":"R46-20250121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41531-021-00199-2","article-title":"Parkinson\u2019s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI.","volume":"7","author":"Depierreux","year":"2021","journal-title":"npj Parkinson\u2019s Dis"},{"key":"R47-20250121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00702-020-02271-2","article-title":"Iron and inflammation: in vivo and post-mortem studies in Parkinson\u2019s disease.","volume":"128","author":"Martin-Bastida","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"R48-20250121","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/mds.27730","article-title":"Ventral posterior substantia nigra iron increases over 3 years in Parkinson\u2019s disease.","volume":"34","author":"Bergsland","year":"2019","journal-title":"Mov Disord"},{"key":"R49-20250121","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2013.09.019","article-title":"Pooled analysis of iron-related genes in Parkinson\u2019s disease: association with transferrin.","volume":"62","author":"Rhodes","year":"2014","journal-title":"Neurobiol Dis"},{"key":"R50-20250121","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41418-020-00698-4","article-title":"Gender biased neuroprotective effect of transferrin receptor 2 deletion in multiple models of Parkinson\u2019s disease.","volume":"28","author":"Milanese","year":"2021","journal-title":"Cell Death Differ"},{"key":"R51-20250121","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13311-018-0656-x","article-title":"Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice.","volume":"15","author":"Belaidi","year":"2018","journal-title":"Neurotherapeutics"},{"key":"R52-20250121","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1096\/fj.04-3486fje","article-title":"Functional relevance of ceruloplasmin mutations in Parkinson\u2019s disease.","volume":"19","author":"Hochstrasser","year":"2005","journal-title":"FASEB J"},{"key":"R53-20250121","doi-asserted-by":"crossref","first-page":"102431","DOI":"10.1016\/j.isci.2021.102431","article-title":"Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis.","volume":"24","author":"Song","year":"2021","journal-title":"iScience"},{"key":"R54-20250121","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.lfs.2008.09.020","article-title":"Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson\u2019s disease-like disorders.","volume":"83","author":"Lee","year":"2008","journal-title":"Life Sci"},{"key":"R55-20250121","doi-asserted-by":"crossref","first-page":"152650","DOI":"10.1016\/j.tox.2020.152650","article-title":"Formaldehyde induces ferroptosis in hippocampal neuronal cells by upregulation of the Warburg effect.","volume":"448","author":"Li","year":"2021","journal-title":"Toxicology"},{"key":"R56-20250121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis: a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC.","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol Dis"},{"key":"R57-20250121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2022.11.018","article-title":"Ketone body beta-hydroxybutyric acid ameliorates dopaminergic neuron injury through modulating zinc finger protein 36\/acyl-CoA synthetase long-chain family member four signaling axis-mediated ferroptosis.","volume":"509","author":"Yu","year":"2023","journal-title":"Neuroscience"},{"key":"R58-20250121","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1021\/jacs.1c08254","article-title":"Radical-trapping antioxidant activity of copper and nickel bis(thiosemicarbazone) complexes underlies their potency as inhibitors of ferroptotic cell death.","volume":"143","author":"Zilka","year":"2021","journal-title":"J Am Chem Soc"},{"key":"R59-20250121","doi-asserted-by":"crossref","first-page":"101328","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1.","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol"},{"key":"R60-20250121","first-page":"5463134","article-title":"Sorting nexin 5 plays an important role in promoting ferroptosis in Parkinson\u2019s disease.","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R61-20250121","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10930-015-9629-7","article-title":"The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells.","volume":"34","author":"Kabiraj","year":"2015","journal-title":"Protein J"},{"key":"R62-20250121","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in Parkinson\u2019s disease.","volume":"106","author":"Monti","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"R63-20250121","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"R64-20250121","doi-asserted-by":"crossref","first-page":"175875","DOI":"10.1016\/j.ejphar.2023.175875","article-title":"Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson\u2019s disease.","volume":"954","author":"Mansour","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R65-20250121","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke.","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"R66-20250121","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nut.2014.07.004","article-title":"Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson\u2019s disease.","volume":"31","author":"Ellwanger","year":"2015","journal-title":"Nutrition"},{"key":"R67-20250121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2017.03.014","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial.","volume":"108","author":"Taghizadeh","year":"2017","journal-title":"Neurochem Int"},{"key":"R68-20250121","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.parkreldis.2015.05.022","article-title":"Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson\u2019s disease.","volume":"21","author":"Yoritaka","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"R69-20250121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","article-title":"Idebenone ameliorates rotenone-induced parkinson\u2019s disease in rats through decreasing lipid peroxidation.","volume":"46","author":"Avci","year":"2021","journal-title":"Neurochem Res"},{"key":"R70-20250121","doi-asserted-by":"crossref","first-page":"153576","DOI":"10.1016\/j.prp.2021.153576","article-title":"Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2\/Keap1\/SLC7A11 pathway in a microglia cell line.","volume":"225","author":"Li","year":"2021","journal-title":"Pathol Res Pract"},{"key":"R71-20250121","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","article-title":"Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson\u2019s disease.","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov Disord"},{"key":"R72-20250121","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JPD-161040","article-title":"Phase IIb study of intranasal glutathione in parkinson\u2019s disease.","volume":"7","author":"Mischley","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"R73-20250121","first-page":"9515","article-title":"Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson\u2019s disease through AKT\/mTOR pathway.","volume":"12","author":"Shi","year":"2020","journal-title":"Aging (Albany N Y)"},{"key":"R74-20250121","doi-asserted-by":"crossref","first-page":"137346","DOI":"10.1016\/j.neulet.2023.137346","article-title":"Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson\u2019s disease.","volume":"810","author":"Zheng","year":"2023","journal-title":"Neurosci Lett"},{"key":"R75-20250121","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","article-title":"Benefits of iron chelators in the treatment of Parkinson\u2019s disease.","volume":"46","author":"Zeng","year":"2021","journal-title":"Neurochem Res"},{"key":"R76-20250121","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease.","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci Rep"},{"key":"R77-20250121","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease.","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"R78-20250121","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson\u2019s disease.","volume":"387","author":"Devos","year":"2022","journal-title":"N Engl J Med"},{"key":"R79-20250121","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1039\/D1DT02604F","article-title":"Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson\u2019s disease.","volume":"51","author":"Lewis","year":"2022","journal-title":"Dalton Trans"},{"key":"R80-20250121","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4103\/1673-5374.371381","article-title":"Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson\u2019s disease.","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res"},{"key":"R81-20250121","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/bioengineering10060727","article-title":"Engineering ferroptosis inhibitors as inhalable nanomedicines for the highly efficient treatment of idiopathic pulmonary fibrosis.","volume":"10","author":"Guo","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"R82-20250121","doi-asserted-by":"crossref","first-page":"102035","DOI":"10.1016\/j.arr.2023.102035","article-title":"Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.","volume":"91","author":"Wang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R83-20250121","doi-asserted-by":"crossref","first-page":"e12938","DOI":"10.1111\/nan.12938","article-title":"Cu(II)(atsm) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis.","volume":"49","author":"Liddell","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R84-20250121","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/med.21939","article-title":"Novel druggable mechanism of Parkinson\u2019s disease: potential therapeutics and underlying pathogenesis based on ferroptosis.","volume":"43","author":"Jiang","year":"2023","journal-title":"Med Res Rev"},{"key":"R85-20250121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics.","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov Disord"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:04:12Z","timestamp":1737410652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041218","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}